NCT04923828

Brief Summary

To investigate PICUs in major cities in China by establishing a high-quality standardized clinical database of PICU inpatients Incidence, fatality rate, pathogen distribution, anti-infective treatment of community-acquired/nosocomial infections in inpatients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Dec 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Dec 2023Dec 2026

First Submitted

Initial submission to the registry

June 7, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 11, 2021

Completed
2.6 years until next milestone

Study Start

First participant enrolled

December 31, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

3 years

First QC Date

June 7, 2021

Last Update Submit

February 12, 2026

Conditions

Keywords

PICUpathogensevers infectiondrug resistance

Outcome Measures

Primary Outcomes (1)

  • Pathogenic spectrum of PICU severe infection

    the 10 years of pathogenic spectrum of PICU severe infection

    2016-2025

Eligibility Criteria

Age1 Month - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

PICU patients with severe infection

You may qualify if:

  • PICU patients with severe infection

You may not qualify if:

  • Non-infected patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

RECRUITING

MeSH Terms

Conditions

Infections

Study Officials

  • Guoping Lu, Doctor

    Children's Hospital of Fudan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Guoping Lu, Doctor

CONTACT

Jing Liu, Master

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2021

First Posted

June 11, 2021

Study Start

December 31, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 17, 2026

Record last verified: 2026-02

Locations